Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 201

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 14
Chunk 201
---
 unit awards is valued using the closing price of the Company’s common stock on the date of grant. The grant date fair value
is recognized over the requisite service period during which an employee and non-employee is required to provide service in exchange for
the award, using the accelerated method with each tranche being expensed over its vesting period. The grant date fair value of employee
and non-employee share options is estimated using the Black-Scholes option pricing model. The risk-free interest rate assumptions were
based upon the observed interest rates appropriate for the expected term of the equity instruments. The expected dividend yield was assumed
to be zero as the Company has not paid any dividends since its inception and does not anticipate paying dividends in the foreseeable future.
The Company accounts for forfeitures as they occur. Starting in 2023, Beyond Air used its own historical volatility as an input for expected
volatility, but due to Beyond Cancer’s lack of marketability, the Company utilizes the implied volatility based on an aggregate
of guideline companies for expected volatility. The Company uses the simplified method to estimate the expected term.

Supplier Concentration

The Company relies on third-party suppliers to provide
materials for its devices and consumables.

In the year ended March 31, 2025, the Company purchased
approximately 85% of its materials from a third-party vendor. In the year ended March 31, 2024, the Company purchased approximately 75%
of its materials from a third-party vendor.

Customer Concentration

For the year ended March 31, 2025, the Company derived 16% and 10% of its revenues from two customers. For the year
ended March 31, 2024, the Company derived 40% and 21% of its revenues from two customers.

Licensed Right to Use
Technology

Licensed right to use technology that is considered
platform technology with alternative future uses is recorded as an intangible asset and is amortized on a straight-line method over its
estimated useful life, determined to be thirteen years.

The expected amortization expense for the next five
years and thereafter is as follows for the year ended March 31 (in thousands):

 SCHEDULE OF FUTURE EXPECTED AMORTIZATION EXPENSE

    2026
     
    $
    205

    2027

    205

    2028

    205

    2029

    205

    2030

    205

    Thereafter